P53-induced protein with a death domain (PIDD): Master of puppets

Oncogene

Volumn 31, Issue 45, 2012, Pages 4733-4739

  Bock, F J ^a   Peintner, L ^a   Tanzer, M ^a   Manzl, C ^a   Villunger, A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Caspase 2; NF B; p53; PIDD; RAIDD

Indexed keywords

CASPASE 2; CISPLATIN; DNA; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; P53 INDUCED PROTEIN WITH A DEATH DOMAIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CHEMOTHERAPY; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; EXON; GERM CELL TUMOR; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; APOPTOSIS; CASPASE 2; CELL SURVIVAL; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; HUMANS; NEOPLASMS; NF-KAPPA B; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEOLYSIS; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84869097490     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.639     Document Type: Review

References (53)

1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461: 1071-1078.
2. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275-283. (Pubitemid 46474662)
3. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 2009; 9: 714-723.
4. Olsson A, Manzl C, Strasser A, Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 2007; 14: 1561-1575. (Pubitemid 47278842)
5. Lin Y, Ma W, Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000; 26: 122-127.
6. Telliez JB, Bean KM, Lin LL. LRDD, a novel leucine rich repeat and death domain containing protein. Biochim Biophys Acta 2000; 1478: 280-288. (Pubitemid 30312885)
7. Tinel A, Janssens S, Lippens S, Cuenin S, Logette E, Jaccard B et al. Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. Embo J 2007; 26: 197-208. (Pubitemid 46094711)
8. Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 2005; 123: 1079-1092. (Pubitemid 41785422)
9. Logette E, Schuepbach-Mallepell S, Eckert MJ, Leo XH, Jaccard B, Manzl C et al. PIDD orchestrates translesion DNA synthesis in response to UV irradiation. Cell Death Differ 2011; 18: 1036-1045.
10. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846. (Pubitemid 38620177)
11. Pick R, Badura S, Bosser S, Zornig M. Upon intracellular processing, the C-terminal death domain-containing fragment of the p53-inducible PIDD/LRDD protein translocates to the nucleoli and interacts with nucleolin. Biochem Biophys Res Commun 2006; 349: 1329-1338. (Pubitemid 44416403)
12. Cuenin S, Tinel A, Janssens S, Tschopp J. p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene 2008; 27: 387-396.
13. Huang L, Han D, Yang X, Qin B, Ji G, Yu L. PIDD4, a novel PIDD isoform without the LRR domain, can independently induce cell apoptosis in cytoplasm. Biochem Biophys Res Commun 2011; 407: 86-91.
14. Heinz LX, Rebsamen M, Rossi DC, Staehli F, Schroder K, Quadroni M et al. The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ 2011 (e-pub ahead of print 9 December 2011; doi:10.1038/cdd.2011.147).
15. Rosenblum JS, Blobel G. Autoproteolysis in nucleoporin biogenesis. Proc Natl Acad Sci U S A 1999; 96: 11370-11375. (Pubitemid 29487387)
16. Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F et al. Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 2009; 185: 291-303.
17. Tinel A, Eckert MJ, Logette E, Lippens S, Janssens S, Jaccard B et al. Regulation of PIDD auto-proteolysis and activity by the molecular chaperone Hsp90. Cell Death Differ 2011; 18: 506-515.
18. Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene 2008; 27: 6194-6206.
19. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009; 284: 21777-21781.
20. Read SH, Baliga BC, Ekert PG, Vaux DL, Kumar S. A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 2002; 159: 739-745. (Pubitemid 36008356)
21. Krumschnabel G, Sohm B, Bock F, Manzl C, Villunger A. The enigma of caspase-2: The laymen's view. Cell Death Differ 2009; 16: 195-207.
22. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-89. (Pubitemid 27024560)
23. Niizuma K, Endo H, Nito C, Myer DJ, Kim GS, Chan PH. The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats. Proc Natl Acad Sci U S A 2008; 105: 16368-16373.
24. Hasegawa H, Yamada Y, Tsukasaki K, Mori N, Tsuruda K, Sasaki D et al. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway. Leukemia 2011; 25: 575-587.
25. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 2006; 25: 5683-5692. (Pubitemid 44389351)
26. Olsson M, Vakifahmetoglu H, Abruzzo PM, Hogstrand K, Grandien A, Zhivotovsky B. DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene 2009; 28: 1949-1959.
27. Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008; 133: 864-877. (Pubitemid 351715394)
28. Kim IR, Murakami K, Chen NJ, Saibil SD, Matysiak-Zablocki E, Elford AR et al. DNA damage- and stress-induced apoptosis occurs independently of PIDD. Apoptosis 2009; 14: 1039-1049.
29. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304-1314. (Pubitemid 28213406)
30. Ho LH, Read SH, Dorstyn L, Lambrusco L, Kumar S. Caspase-2 is required for cell death induced by cytoskeletal disruption. Oncogene 2008; 27: 3393-3404. (Pubitemid 351769315)
31. Ho LH, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S. A tumor suppressor function for caspase-2. Proc Natl Acad Sci U S A 2009; 106: 5336-5341.
32. Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, Hakem R et al. Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci U S A 2005; 102: 14314-14320.
33. Janssens S, Tschopp J. Signals from within: The DNA-damage-induced NF-kappaB response. Cell Death Differ 2006; 13: 773-784.
34. Miyamoto S. Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res 2011; 21: 116-130.
35. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene 2006; 25: 6758-6780.
36. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003; 115: 565-576. (Pubitemid 37506045)
37. Lee MH, Mabb AM, Gill GB, Yeh ET, Miyamoto S. NF-kappaB induction of the SUMO Protease SENP2: a negative feedback loop to attenuate cell survival response to genotoxic stress. Mol Cell 2011; 43: 180-191.
38. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006; 311: 1141-1146.
39. Jin HS, Lee DH, Kim DH, Chung JH, Lee SJ, Lee TH. cIAP1, cIAP2, and XIAP act cooperatively via non-redundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res 2009; 69: 1782-1791.
40. Stilmann M, Hinz M, Arslan SC, Zimmer A, Schreiber V, Scheidereit C. A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol Cell 2009; 36: 365-378.
41. Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol 2006; 8: 986-993. (Pubitemid 44314730)
42. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitinmediated NF-kappaB activation. Mol Cell 2010; 40: 63-74.
43. Yang Y, Xia F, Hermance N, Mabb A, Simonson S, Morrissey S et al. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol 2011; 31: 2774-2786.
44. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, Miyamoto S et al. ATM- and NEMOdependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 2010; 40: 75-86.
45. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-310. (Pubitemid 37328783)
46. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12: 715-723.
47. Heinen CD, Schmutte C, Fishel R. DNA repair and tumorigenesis: lessons from hereditary cancer syndromes. Cancer Biol Ther 2002; 1: 477-485.
48. Bradley G, Tremblay S, Irish J, MacMillan C, Baker G, Gullane P et al. The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. Br J Cancer 2007; 96: 1425-1432. (Pubitemid 46685800)
49. Grosjean-Raillard J, Tailler M, Ades L, Perfettini JL, Fabre C, Braun T et al. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 2009; 28: 1099-1109.
50. Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene 2005; 24: 6090-6100. (Pubitemid 43080059)
51. Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev 2010; 24: 837-852.
52. Oliver TG, Meylan E, Chang GP, Xue W, Burke JR, Humpton TJ et al. Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop. Mol Cell 2011; 43: 57-71.
53. Sohn D, Budach W, Janicke RU. Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell Death Differ 2011; 18: 1664-1674.